1362TiP Capmatinib versus docetaxel in pretreated patients with MET exon 14 skipping-mutated locally advanced or metastatic NSCLC: The GeoMETry-III phase III study

Souquet, P-J. ; Kim, S-W. ; Solomon, B. ; Vansteenkiste, J.F. ; Carbini, M. ; Jary, A. ; Glaser, S. ; Agostinho, A. Chassot ; Wolf, J.

Annals of oncology, 2021-09, Vol.32, p.S1033-S1033 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível